Published in J Clin Psychopharmacol on August 01, 2011
Methamphetamine-associated cardiomyopathy. Clin Cardiol (2013) 0.99
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction (2013) 0.95
Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.88
Test-retest reliability of eye tracking during the visual probe task in cocaine-using adults. Drug Alcohol Depend (2014) 0.86
Drug-related stimuli impair inhibitory control in cocaine abusers. Drug Alcohol Depend (2013) 0.85
Methamphetamine self-administration in humans during D-amphetamine maintenance. J Clin Psychopharmacol (2014) 0.84
Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine. Pharmacol Biochem Behav (2014) 0.84
Relationship between discriminative stimulus effects and plasma methamphetamine and amphetamine levels of intramuscular methamphetamine in male rhesus monkeys. Pharmacol Biochem Behav (2015) 0.80
Human drug discrimination: A primer and methodological review. Exp Clin Psychopharmacol (2016) 0.77
Cocaine-related stimuli impair inhibitory control in cocaine users following short stimulus onset asynchronies. Addiction (2015) 0.77
Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine. Pharmacol Biochem Behav (2016) 0.77
Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys. Behav Pharmacol (2016) 0.75
Alcohol Administration Increases Cocaine Craving But Not Cocaine Cue Attentional Bias. Alcohol Clin Exp Res (2015) 0.75
A pilot investigation of acute inhibitory control training in cocaine users. Drug Alcohol Depend (2017) 0.75
Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment. Behav Pharmacol (2016) 0.75
Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine. Drug Alcohol Depend (2017) 0.75
Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther (1971) 4.30
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci (1995) 1.91
The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007. Drug Alcohol Rev (2008) 1.77
A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry (2007) 1.61
Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther (1992) 1.50
Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther (2003) 1.40
The Medicare hospice payment system: a consideration of potential refinements. Health Care Financ Rev (2009) 1.32
Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci (1989) 1.32
Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology (2005) 1.21
Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther (1998) 1.19
Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol Psychiatry (1996) 1.14
Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology (Berl) (2000) 1.12
Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. J Pharmacol Exp Ther (2008) 1.06
Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther (1994) 1.06
The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug Alcohol Depend (2002) 1.03
Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology (Berl) (1991) 1.02
Aripiprazole. CNS Drugs (2002) 1.02
Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures. Behav Cogn Neurosci Rev (2003) 1.00
High dose pimozide does not block amphetamine-induced euphoria in normal volunteers. Pharmacol Biochem Behav (1997) 1.00
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug Alcohol Depend (2006) 1.00
Effects of the NMDA antagonist memantine on human methamphetamine discrimination. Psychopharmacology (Berl) (2002) 0.98
Alprazolam attenuates the behavioral effects of d-amphetamine in humans. J Clin Psychopharmacol (2004) 0.97
Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify). Exp Clin Psychopharmacol (2008) 0.96
The discriminative stimulus effects of methamphetamine in pigeons. Psychopharmacology (Berl) (1995) 0.95
Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J Pharmacol Exp Ther (1999) 0.95
Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors. J Pharmacol Exp Ther (2004) 0.94
Drug tasting may confound human drug discrimination studies. Psychopharmacology (Berl) (1996) 0.93
Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol (2008) 0.92
Methamphetamine users in the psychiatric emergency services: a case-control study. Am J Drug Alcohol Abuse (2007) 0.86
Oxazepam does not modulate the behavioral effects of d-amphetamine in humans. Pharmacol Biochem Behav (2005) 0.84
Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans. Pharmacol Biochem Behav (1999) 0.84
Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend (2002) 3.15
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Ann N Y Acad Sci (2010) 1.45
Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther (2003) 1.40
Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology (Berl) (2006) 1.40
Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) (2005) 1.39
Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control. J Psychopharmacol (2005) 1.31
The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. Addict Behav (2006) 1.29
Cocaine choice in humans during D-amphetamine maintenance. J Clin Psychopharmacol (2010) 1.26
Adolescent OxyContin Abuse. J Am Acad Child Adolesc Psychiatry (2004) 1.23
Methylphenidate increases cigarette smoking. Psychopharmacology (Berl) (2005) 1.23
Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology (2005) 1.21
Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. Drug Alcohol Depend (2008) 1.15
Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend (2010) 1.15
Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol. Psychopharmacology (Berl) (2008) 1.13
Discriminative-stimulus effects of modafinil in cocaine-trained humans. Drug Alcohol Depend (2002) 1.13
Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend (2002) 1.12
Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol (2004) 1.12
A pharmacological analysis of stimulant-induced increases in smoking. Psychopharmacology (Berl) (2007) 1.11
Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend (2003) 1.09
Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) (2004) 1.08
Agonist replacement for stimulant dependence: a review of clinical research. Curr Pharm Des (2013) 1.08
Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. J Pharmacol Exp Ther (2008) 1.06
Acute effects of cocaine in two models of inhibitory control: implications of non-linear dose effects. Addiction (2006) 1.04
Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans. Eur J Pharmacol (2010) 1.03
Fixation time is a sensitive measure of cocaine cue attentional bias. Addiction (2014) 1.02
Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance. Drug Alcohol Depend (2007) 1.02
Alternative reinforcer response cost impacts cocaine choice in humans. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.02
Adverse impact of a history of violence for women with breast, cervical, endometrial, or ovarian cancer. Obstet Gynecol (2006) 1.02
Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacol Biochem Behav (2007) 1.01
Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers. Pharmacol Biochem Behav (2010) 1.01
Substitution profile of the cannabinoid agonist nabilone in human subjects discriminating δ9-tetrahydrocannabinol. Clin Neuropharmacol (2010) 1.00
Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures. Behav Cogn Neurosci Rev (2003) 1.00
Prescription opiate misuse among rural stimulant users in a multistate community-based study. Am J Drug Alcohol Abuse (2009) 1.00
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug Alcohol Depend (2006) 1.00
Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults. Exp Clin Psychopharmacol (2007) 0.98
Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis. Drug Alcohol Depend (2003) 0.97
Alprazolam attenuates the behavioral effects of d-amphetamine in humans. J Clin Psychopharmacol (2004) 0.97
Resting glutamate levels and rapid glutamate transients in the prefrontal cortex of the Flinders Sensitive Line rat: a genetic rodent model of depression. Neuropsychopharmacology (2011) 0.97
Agonist replacement therapy for cocaine dependence: a translational review. Future Med Chem (2012) 0.97
Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans. Exp Clin Psychopharmacol (2005) 0.96
Social and environmental influences on opioid sensitivity in rats: importance of an opioid's relative efficacy at the mu-receptor. Psychopharmacology (Berl) (2005) 0.96
Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC. Drug Alcohol Depend (2012) 0.95
Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Exp Clin Psychopharmacol (2006) 0.94
Decreased dopamine D4 receptor expression increases extracellular glutamate and alters its regulation in mouse striatum. Neuropsychopharmacology (2008) 0.94
Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics. Exp Clin Psychopharmacol (2009) 0.94
Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization. Neuropsychopharmacology (2007) 0.94
The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance. Am J Drug Alcohol Abuse (2007) 0.93
Performance and subjective effects of diazepam and d-amphetamine in high and low sensation seekers. Behav Pharmacol (2009) 0.93
Human sex differences in d-amphetamine self-administration. Addiction (2010) 0.92
Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC. Drug Alcohol Depend (2011) 0.92
Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule. Behav Pharmacol (2010) 0.91
Alcohol choice and amphetamine effects in light and moderate drinkers. Alcohol Clin Exp Res (2003) 0.89
Lack of tolerance to the disinhibiting effects of alcohol in heavy drinkers. Psychopharmacology (Berl) (2012) 0.89
Methylphenidate increases cigarette smoking in participants with ADHD. Psychopharmacology (Berl) (2011) 0.89
Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity. Appetite (2004) 0.89
Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans. Drug Alcohol Depend (2004) 0.89
Influence of acute bupropion pre-treatment on the effects of intranasal cocaine. Addiction (2012) 0.89